Based on our observations, we conclude that when experimental methods are used to overexpress Cx43, whether the breast cancer cell is sensitive to HER2 inhibitors or resistant to HER2 inhibitors dictates if the exogenously expressed Cx43 can induce the formation of functional gap junctions. The gene discussed is ERBB2; the disease is breast cancer.